Association of Wiskott-Aldrich syndrome protein (WASp) in epigenetic regulation of B cell differentiation in non-small-cell lung cancer (NSCLC).

B cell differentiating factors B cells Cytokines Epigenetics Non-small-cell lung cancer (NSCLC) T helper (TH) cells Tumor suppressor Wiskott-Aldrich syndrome protein (WASp)

Journal

Medical oncology (Northwood, London, England)
ISSN: 1559-131X
Titre abrégé: Med Oncol
Pays: United States
ID NLM: 9435512

Informations de publication

Date de publication:
25 Dec 2023
Historique:
received: 18 09 2023
accepted: 21 11 2023
medline: 26 12 2023
pubmed: 26 12 2023
entrez: 25 12 2023
Statut: epublish

Résumé

Non-small-cell lung cancer (NSCLC) accounts for approximately 85% of all lung cancer which is the deadliest type of cancer for both men and women. Previous studies already showed that cell-intrinsic loss of WASp causes B cell tolerance and WASp deficiency in T helper (T

Identifiants

pubmed: 38146020
doi: 10.1007/s12032-023-02264-7
pii: 10.1007/s12032-023-02264-7
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

28

Subventions

Organisme : Science and Engineering Research Board (SERB), Department of Science and Technology (DST), Govt. of India
ID : ECR/2016/000965

Informations de copyright

© 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Références

Henderson BE, Ross RK, Pike MC. Toward the primary prevention of cancer. Science. 1991;254(5035):1131–8. https://doi.org/10.1126/science.1957166 .
doi: 10.1126/science.1957166 pubmed: 1957166
Lu F, Zhang HT. DNA methylation and nonsmall cell lung cancer. Anat Rec Adv Integr Anat Evol Biol. 2011;294(11):1787–95. https://doi.org/10.1002/ar.21471 .
doi: 10.1002/ar.21471
Cardona-Monzonís A, Ortega ÁL, Carretero J, García-Giménez JL, Mena-Mollá S. Epigenetics and precision medicine in lung cancer. In: Epigenetics in precision medicine. New York: Academic Press; 2022. p. 109–45.
doi: 10.1016/B978-0-12-823008-4.00007-X
Baylin SB, Jones PA. Epigenetic determinants of cancer. Cold Spring Harb Perspect Biol. 2016;8(9): a019505. https://doi.org/10.1101/cshperspect.a019505 .
doi: 10.1101/cshperspect.a019505 pubmed: 27194046 pmcid: 5008069
Schmidt M, Böhm D, von Törne C, et al. The humoral immune system has a key prognostic impact in node-negative breast cancer. Can Res. 2008;68(13):5405–13. https://doi.org/10.1158/0008-5472.CAN-07-5206 .
doi: 10.1158/0008-5472.CAN-07-5206
Guillem EB, Sampsel JW. Antitumor-associated antigens IgGs: dual positive and negative potential effects for cancer therapy. Adv Exp Med Biol. 2006;587:341–74. https://doi.org/10.1007/978-1-4020-5133-3_26 .
doi: 10.1007/978-1-4020-5133-3_26 pubmed: 17163176
Guo FF, Cui JW. The role of tumor-infiltrating B cells in tumor immunity. J Oncol. 2019;2019:2592419. https://doi.org/10.1155/2019/2592419 .
doi: 10.1155/2019/2592419 pubmed: 31662750 pmcid: 6778893
Liu C, Bai X, Wu J, et al. N-wasp is essential for the negative regulation of B cell receptor signaling. PLoS Biol. 2013;11(11): e1001704. https://doi.org/10.1371/journal.pbio.1001704 .
doi: 10.1371/journal.pbio.1001704 pubmed: 24223520 pmcid: 3818172
Rey-Suarez I, Wheatley BA, Koo P, et al. WASP family proteins regulate the mobility of the B cell receptor during signaling activation. Nat Commun. 2020;11(1):439. https://doi.org/10.1038/s41467-020-14335-8 .
doi: 10.1038/s41467-020-14335-8 pubmed: 31974357 pmcid: 6978525
Coronella-Wood JA, Hersh EM. Naturally occurring B-cell responses to breast cancer. Cancer Immunol Immunother. 2003;52(12):715–38. https://doi.org/10.1007/s00262-003-0409-4 .
doi: 10.1007/s00262-003-0409-4 pubmed: 12920480
Sadhukhan S, Sarkar K, Taylor M, Candotti F, Vyas YM. The nuclear role of WASp in gene transcription is uncoupled from its ARP2/3-dependent cytoplasmic role in actin polymerization. J Immunol. 2014;193(1):150–60. https://doi.org/10.4049/jimmunol.1302923 .
doi: 10.4049/jimmunol.1302923 pubmed: 24872192
Pal R, Rakshit S, Shanmugam G, et al. Involvement of Xeroderma Pigmentosum Complementation Group G (XPG) in epigenetic regulation of T-Helper (T
doi: 10.1016/j.imbio.2022.152259 pubmed: 36037675
Taylor M, Sadhukhan S, Kottangada P, et al. Nuclear role of WASp in the pathogenesis of dysregulated T
doi: 10.1126/scitranslmed.3000813 pubmed: 20574068 pmcid: 2943146
Sarkar K, Sadhukhan S, Han S, Vyas YM. Disruption of hSWI/SNF complexes in T cells by WAS mutations distinguish X-linked thrombocytopenia from Wiskott-Aldrich syndrome. Blood. 2014;124(23):3409–19. https://doi.org/10.1182/blood-2014-07-587642 .
doi: 10.1182/blood-2014-07-587642 pubmed: 25253772 pmcid: 4246038
Sarkar K, Han S, Wen K, Ochs H, Dupré L, Seidman M, Go Y. R-loops cause genomic instability in T helper lymphocytes from patients with Wiskott-Aldrich syndrome. J Allergy Clin Immunol. 2018;142(1):219–34. https://doi.org/10.1016/j.jaci.2017.11.023 .
doi: 10.1016/j.jaci.2017.11.023 pubmed: 29248492
Sarkar K, Sadhukhan S, Han S, Vyas YM. SUMOylation-disrupting WAS mutation converts WASp from a transcriptional activator to a repressor of NF- B response genes in T cells. Blood. 2015;126(14):1670–82. https://doi.org/10.1182/blood-2015-05-646182 .
doi: 10.1182/blood-2015-05-646182 pubmed: 26261240 pmcid: 4591791
Bochynska A, Lüscher-Firzlaff J, Lüscher B. Modes of interaction of KMT2 histone H3 lysine 4 methyltransferase/COMPASS complexes with chromatin. Cells. 2018;7(3):17. https://doi.org/10.3390/cells7030017 .
doi: 10.3390/cells7030017 pubmed: 29498679 pmcid: 5870349
Sharma S, Kelly TK, Jones PA. Epigenetics in cancer. Carcinogenesis. 2010;31(1):27–36. https://doi.org/10.1093/carcin/bgp220 .
doi: 10.1093/carcin/bgp220 pubmed: 19752007
van Weverwijk A, de Visser KE. Mechanisms driving the immunoregulatory function of cancer cells. Nat Rev Cancer. 2023;23:193–215. https://doi.org/10.1038/s41568-022-00544-4 .
doi: 10.1038/s41568-022-00544-4 pubmed: 36717668
Han SS, Wen KK, Vyas YM. Deficiency of Wiskott-Aldrich syndrome protein has opposing effect on the pro-oncogenic pathway activation in nonmalignant versus malignant lymphocytes. Oncogene. 2021;40(2):345–54. https://doi.org/10.1038/s41388-020-01533-3 .
doi: 10.1038/s41388-020-01533-3 pubmed: 33139832
Westerberg L, Larsson M, Hardy SJ, Fernández C, Thrasher AJ, Severinson E. Wiskott-Aldrich syndrome protein deficiency leads to reduced B-cell adhesion, migration, and homing, and a delayed humoral immune response. Blood. 2005;105(3):1144–52. https://doi.org/10.1182/blood-2004-03-1003 .
doi: 10.1182/blood-2004-03-1003 pubmed: 15383456
Sun X, Wei Y, Lee PP, Ren B, Liu C. The role of WASp in T cells and B cells. Cell Immunol. 2019;341: 103919. https://doi.org/10.1016/j.cellimm.2019.04.007 .
doi: 10.1016/j.cellimm.2019.04.007 pubmed: 31047647
Santos PM, Borghesi L. Molecular resolution of the B cell landscape. Curr Opin Immunol. 2011;23(2):163–70. https://doi.org/10.1016/j.coi.2010.11.014 .
doi: 10.1016/j.coi.2010.11.014 pubmed: 21236654 pmcid: 3073704
Taylor MD, Sadhukhan S, Kottangada P, et al. Nuclear role of WASp in the pathogenesis of dysregulated TH1 immunity in human Wiskott-Aldrich syndrome. Sci Transl Med. 2010;2(37):44. https://doi.org/10.1126/scitranslmed.3000813 .
doi: 10.1126/scitranslmed.3000813
Biswas A, Shouval DS, Griffith A, et al. WASP-mediated regulation of anti-inflammatory macrophages is IL-10 dependent and is critical for intestinal homeostasis. Nat Commun. 2018;9(1):1779. https://doi.org/10.1038/s41467-018-03670-6 .
doi: 10.1038/s41467-018-03670-6 pubmed: 29725003 pmcid: 5934380
Ferreirós-Vidal I, Carroll T, Taylor B, et al. Genome-wide identification of Ikaros targets elucidates its contribution to mouse B-cell lineage specification and pre-B–cell differentiation. Blood J Am Soc Hematol. 2013;121(10):1769–82. https://doi.org/10.1182/blood-2012-08-450114 .
doi: 10.1182/blood-2012-08-450114
Holmes ML, Pridans C, Nutt SL. The regulation of the B-cell gene expression programme by Pax5. Immunol Cell Biol. 2008;86(1):47–53. https://doi.org/10.1038/sj.icb.7100134 .
doi: 10.1038/sj.icb.7100134 pubmed: 17998914
Yang X, Wang B, Cao X. Transcriptional suppression of CD8+ T cell exhaustion for improving T cell immunotherapy. Cancer Commun. 2021;41(11):1228. https://doi.org/10.1002/cac2.12222 .
doi: 10.1002/cac2.12222
Libregts SF, Gutiérrez L, de Bruin AM, et al. Chronic IFN-γ production in mice induces anemia by reducing erythrocyte life span and inhibiting erythropoiesis through an IRF-1/PU. 1 axis. Blood J Am Soc Hematol. 2011;118(9):2578–88. https://doi.org/10.1182/blood-2010-10-315218 .
doi: 10.1182/blood-2010-10-315218
Engeland K. Cell cycle regulation: p53–p21-RB signaling. Cell Death Differ. 2022;29(5):946–60. https://doi.org/10.1038/s41418-022-00988-z .
doi: 10.1038/s41418-022-00988-z pubmed: 35361964 pmcid: 9090780
Yang J, Huang Y, Song M, et al. SPC25 promotes proliferation and stemness of hepatocellular carcinoma cells via the DNA-PK/AKT/Notch1 signaling pathway. Int J Biol Sci. 2022;18(14):5241–59. https://doi.org/10.7150/ijbs.71694 .
doi: 10.7150/ijbs.71694 pubmed: 36147467 pmcid: 9461674
Pathania R, Ramachandran S, Mariappan G, et al. Combined inhibition of DNMT and HDAC blocks the tumorigenicity of cancer stem-like cells and attenuates mammary tumor growth DNMT and HDAC inhibitors alter cancer stem cell signaling. Can Res. 2016;76(11):3224–35. https://doi.org/10.1158/0008-5472.CAN-15-2249 .
doi: 10.1158/0008-5472.CAN-15-2249
Hwang HK, Kim HI, Kim SH, et al. Prognostic impact of the tumor-infiltrating regulatory T-cell (Foxp3+)/activated cytotoxic T lymphocyte (granzyme CD19+B) ratio on resected left-sided pancreatic cancer. Oncol Lett. 2016;12(6):4477–84. https://doi.org/10.3892/ol.2016.5252 .
doi: 10.3892/ol.2016.5252 pubmed: 28105157 pmcid: 5228542
Chatterjee A, Rodger EJ, Eccles MR. Epigenetic drivers of tumourigenesis and cancer metastasis. In: Seminars in cancer biology, vol. 51. New York: Academic Press; 2018. p. 149–59.
Adriani M, Aoki J, Horai R, Thornton AM, Konno A, Kirby M, Anderson SM, Siegel RM, Candotti F, Schwartzberg PL. Impaired in vitro regulatory T cell function associated with Wiskott-Aldrich syndrome. Clin Immunol (Orlando, FL). 2007;124(1):41–8. https://doi.org/10.1016/j.clim.2007.02.001 .
doi: 10.1016/j.clim.2007.02.001
Zan H, Casali P. Epigenetics of peripheral B-cell differentiation and the antibody response. Front Immunol. 2015;6:631. https://doi.org/10.3389/fimmu.2015.00631 .
doi: 10.3389/fimmu.2015.00631 pubmed: 26697022 pmcid: 4677338

Auteurs

Nikhil Chandnani (N)

Department of Biotechnology, SRM Institute of Science and Technology, Kattankulathur, Tamil Nadu, 603203, India.

Ayush Mandal (A)

Department of Biotechnology, SRM Institute of Science and Technology, Kattankulathur, Tamil Nadu, 603203, India.

Ishika Gupta (I)

Department of Biotechnology, SRM Institute of Science and Technology, Kattankulathur, Tamil Nadu, 603203, India.

Oishi Mukherjee (O)

Department of Biotechnology, SRM Institute of Science and Technology, Kattankulathur, Tamil Nadu, 603203, India.

Sudeshna Rakshit (S)

Department of Biotechnology, SRM Institute of Science and Technology, Kattankulathur, Tamil Nadu, 603203, India.

Geetha Shanmugam (G)

Department of Biotechnology, SRM Institute of Science and Technology, Kattankulathur, Tamil Nadu, 603203, India.

Melvin George (M)

Department of Clinical Pharmacology, SRM Medical College Hospital and Research Centre, Kattankulathur, Tamil Nadu, 603203, India.

Koustav Sarkar (K)

Department of Biotechnology, SRM Institute of Science and Technology, Kattankulathur, Tamil Nadu, 603203, India. koustavsarkar@gmail.com.

Classifications MeSH